- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04983316
TPF Machine Learning Algorithms
Operative or Nonoperative Management of Tibial Plateau Fractures? Application of Machine Learning Algorithms to Assist in Treatment Decision
Study Overview
Status
Conditions
Detailed Description
The overall goal is to adopt a machine learning technique to decide whether operative or non-operative treatment will result in the best patient-outcome.
The primary objectives are to identify the most suitable machine learning algorithm to predict the best treatment for future patients. Whether conservative or operative treatment will lead to the best patient outcome, will be decided on the predicted KOOS score. Several input factors, such as treatment (conservative or operative), number of fracture fragments, location of the fracture, soft tissue involvement,…for each patient will be used as training data for the algorithm. Some of these input data will be derived from CT-scans. Therefore, the CT scans will be segmented in Mimics, for which UZ Leuven recently purchased licenses. The output variable of the training data will be the KOOS score of each patient. Based on the input and output variable, the algorithm will determine a relation between these. For future patients of which the input variable are known, the output variable (=KOOS score) will be predicted both in case of operative and conservative treatment. We hypothesize that the prediction will be improved by adding more input data over time.
To secondary objective is to identify clinical and radiological factors that help predicting the best treatment for future patients.
As an outlook, the machine learning technique could be implemented in the future in clinical practice and utilized as a patient-specific planning tool for tibial plateau fracture management by aiding the surgeon to select the best treatment for a given case. The collected data in this registry will be used to validate the machine learning model. Patients will not yet be treated based on the results of the developed model, the trauma surgeon is responsible to decide which treatment option is best for the patient.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgium, 3000
- UZ Leuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age > 18 years
- Proximal tibia plateau fracture
- Patient is able to attend follow-up visits
Exclusion Criteria:
- Age < 18 years
- Bilateral fractures
- Neurologic disorders (ie paraplegia, CVA, dementia etc.)
- Not understanding Dutch or English
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Machine learning algorithm
Time Frame: 1 year
|
To identify the most suitable machine learning algorithm that predicts the best treatment for future patients.
The prediction will be improved over time by additional input.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical factors
Time Frame: 1 year
|
To identify clinical factors that help predicting the best treatment for future patients
|
1 year
|
|
Radiological factors
Time Frame: 1 year
|
To identify radiological factors that help predicting the best treatment for future patients
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Harm Hoekstra, Prof. MD, UZ Leuven
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S64352
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tibial Plateau Fracture
-
Pedro-José Torrijos-GarridoRecruitingTibial Plateau FractureSpain
-
Second Affiliated Hospital of Soochow UniversityCompletedTibial Plateau FractureChina
-
National Trauma CenterCompletedTibial Plateau Fracture | Tibial Plateau Fractures
-
Second Affiliated Hospital of Soochow UniversityCompleted
-
Poitiers University HospitalCompletedSchatzker Type 2 or 3 Tibial Plateau FractureFrance, Martinique
-
University of UtahEnrolling by invitationTibial Shaft Fracture | Tibial Plateau FractureUnited States
-
Radboud University Medical CenterMassachusetts General Hospital; Flinders Medical CenterNot yet recruitingTibial Plateau FractureUnited States, Australia, Netherlands
-
Sohag Universitysohag university hospitalRecruitingTibial Plateau Fractures Schatzker Type IIEgypt
-
Assiut UniversityTexas Tech University Health Sciences CenterCompletedFracture of Tibia Proximal PlateauEgypt
-
Major Extremity Trauma Research ConsortiumUnited States Department of DefenseCompletedPilon Fracture | Tibial Plateau Fracture | Distal Femur Fracture | Distal Tibia FractureUnited States